Spring Co-Op 2027, Commercial Analytics, Market Access
Vertex Pharmaceuticals
Summary
The Vertex Commercial Analytics, Market Access Co-Op is a 6-month experiential training program for students currently working towards an undergraduate or advanced degree in Engineering, Statistics, Analytics, STEM, or other related fields.
Job description
What you will be doing
US Market Access analytics team functions as an analytics center of excellence for the market access strategy, trade & distribution, revenue forecasting and pricing teams. The analytics team supports use cases that help the different commercial business units ensure that patients with a script for Vertex products have access to the products through their health plans, pharmacies and sites-of-care. The co-op commercial analytics will work with the US market access analytics team to work on forecasting and regression use cases that can help identify key drivers and barriers towards patient access for our pain and cystic fibrosis portfolio.
Key Responsibilities
- Demand forecasting for pharmacies and hospitals
- Assessing the performance of contracts with payers and delivery networks
- Creating performance scorecards for payers
- Performing key driver analysis for identifying drivers of sales and access performance
The co-op will report to the market access data analytics lead and work with them to learn about the data assets, business dynamics and create analytics scripts and reports and manage their tasks in collaboration with the data governance lead.
Qualifications
- A bachelor's degree in quantitative discipline like engineering, statistics, analytics, computer science
- Currently pursuing a master's degree in quantitative discipline or a STEM focused MBA
- Tools & technologies: SQL, Python (Pandas, sklearn)/R, Excel
- Quantitative Skills: Regression & hypothesis testing, key driver analysis, machine learning (classification), time series analysis, forecasting algorithms, SQL analytical window functions
- Legal authorization to work in the United States, now and in the future
- You must be enrolled in an advanced degree program if graduating before May 2027
- You must be available to work full-time, 40 hours per week from January – July 2027
Program Details
- Full-time, paid co-op $25.00 – 35.00 USD/hour
- Program Dates: January – July 2027
- Application Deadline: November 15th, 2026
Requirements
- A bachelor's degree in quantitative discipline like engineering, statistics, analytics, computer science
- Currently pursuing a master's degree in quantitative discipline or a STEM focused MBA
- Tools & technologies: SQL, Python (Pandas, sklearn)/R, Excel
- Quantitative Skills: Regression & hypothesis testing, key driver analysis, machine learning (classification), time series analysis, forecasting algorithms, SQL analytical window functions
- Legal authorization to work in the United States, now and in the future
- You must be enrolled in an advanced degree program if graduating before May 2027
- You must be available to work full-time, 40 hours per week from January – July 2027
Benefits
- Free 24/7 onsite gym access
- Free group exercise classes
- Subsidized commuter benefits
- Free daily breakfast
- Career development opportunities
- Social events
- Paid time off
- Educational assistance
- Student loan repayment
- 401(k)
- Matching charitable donations
Company overview
Vertex Pharmaceuticals is a global biotechnology company headquartered in Boston, Massachusetts, founded in 1989. The company specializes in discovering, developing, and commercializing transformative medicines for serious diseases, with a primary focus on cystic fibrosis (CF). Vertex has pioneered breakthrough therapies including TRIKAFTA/KAFTRIO, SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO, which collectively treat approximately 90% of CF patients. Beyond CF, the company has expanded its portfolio to include treatments for sickle cell disease, transfusion-dependent beta thalassemia, acute pain, and has robust clinical pipelines in APOL1-mediated kidney disease, type 1 diabetes, myotonic dystrophy type 1, and alpha-1 antitrypsin deficiency. Vertex employs approximately 6,100 people globally and maintains research facilities in San Diego, California, and Milton Park, Oxfordshire, England. The company is publicly traded on NASDAQ (VRTX) and is recognized as one of the industry's top workplaces, consistently earning accolades for its innovative culture and patient-focused approach to drug development.